We are proud to have been recognized as a finalist for the 2024 Wisconsin Innovation Awards! This annual award is given to companies and individuals across multiple business sectors who are developing groundbreaking ideas and driving innovation in the state of Wisconsin.
One of MDG’s many innovation pipelines is dedicated to identifying microbial strains for therapeutic use in probiotics. We use our extensive knowledge of microbial genomics alongside testing methods like in vivo functional screening to discover probiotics that have tangible and clear benefits in the human body.
“Each person’s microbiome is unique, which makes developing effective probiotic therapies a complex challenge,” says Kyle Leistikow, our CORE Innovation–Research Manager. “This innovation enables us to more precisely identify and evaluate probiotic strains with specific, beneficial effects—helping us unlock the potential of these tiny microbes to address big health problems.”
Check out the video below to hear how MDG’s innovation is helping us fulfill our mission to Feed, Clean, Save the World.
